Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 212 entries
View as:

The Impact of Resistance Training on Type 2 Diabetes Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02413060 Org: User:
Start: 03/31/15 End: 03/31/16 Due: 03/31/17

Comparison of Body Weight Change Through Different Smeglutide Administration Methods

Phase: N/A Priority: Normal
NCT ID: NCT05616052 Org: User:
Start: 12/01/22 End: 12/01/23 Due: 12/01/24

Postoperative Thrombosis Prevention in Patients With CD

Phase: N/A Priority: Normal
NCT ID: NCT04486859 Org: User:
Start: 12/01/20 End: 05/30/25 Due: 05/30/26

Thyroid Hormones Effect on Brown Adipose Tissue

Phase: N/A Priority: Normal
NCT ID: NCT01376648 Org: User:
Start: 12/31/09 End: 05/31/12 Due: 05/31/13

Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

Phase: N/A Priority: Normal
NCT ID: NCT05401071 Org: User:
Start: 01/13/23 End: 11/01/27 Due: 11/01/28

Radiomic and Pathomic Study of Pituitary Adenoma Using Machine Learning

Phase: N/A Priority: Normal
NCT ID: NCT05108064 Org: User:
Start: 01/01/19 End: 12/31/24 Due: 12/31/25

mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03365765 Org: User:
Start: 02/12/18 End: 12/31/22 Due: 12/31/23

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06148220 Org: User:
Start: 10/01/23 End: 09/01/24 Due: 09/01/25

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT06943729 Org: User:
Start: 04/30/25 End: 04/30/27 Due: 04/30/28

Research of Brachial Plexus Anatomy

Phase: N/A Priority: Normal
NCT ID: NCT06901063 Org: User:
Start: 04/01/25 End: 08/30/25 Due: 08/30/26

Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg

Phase: N/A Priority: Normal
NCT ID: NCT06900166 Org: User:
Start: 04/01/25 End: 04/30/29 Due: 04/30/30

Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging

Phase: N/A Priority: Normal
NCT ID: NCT06827678 Org: User:
Start: 08/01/22 End: 07/30/27 Due: 07/30/28

MDR-TB Close Contacts Tracing in China (TCCT Study)

Phase: N/A Priority: Normal
NCT ID: NCT04484129 Org: User:
Start: 07/21/20 End: 12/31/22 Due: 12/31/23

A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique

Phase: N/A Priority: Normal
NCT ID: NCT06300879 Org: User:
Start: 01/01/24 End: 06/30/26 Due: 06/30/27

Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)

Phase: N/A Priority: Normal
NCT ID: NCT06553911 Org: User:
Start: 04/01/22 End: 12/01/26 Due: 12/01/27

Study of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04260295 Org: User:
Start: 11/01/19 End: 07/31/21 Due: 07/31/22

Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02305407 Org: User:
Start: 03/31/16 End: 05/31/18 Due: 05/31/19

Genome-wide Association Study of Pituitary Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01442220 Org: User:
Start: 09/30/11 End: 07/31/14 Due: 07/31/15

The TMS Treatment for Postoperative Headache in GH Tumor

Phase: N/A Priority: Normal
NCT ID: NCT04529356 Org: User:
Start: 09/01/20 End: 09/30/22 Due: 09/30/23

NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB

Phase: N/A Priority: Normal
NCT ID: NCT03604848 Org: User:
Start: 08/05/18 End: 08/04/24 Due: 08/04/25

Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO

Phase: N/A Priority: Normal
NCT ID: NCT03504527 Org: User:
Start: 05/01/18 End: 05/01/19 Due: 05/01/20

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Phase: N/A Priority: Normal
NCT ID: NCT06649721 Org: User:
Start: 11/27/24 End: 06/30/27 Due: 06/30/28

Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives

Phase: N/A Priority: Normal
NCT ID: NCT04531124 Org: User:
Start: 09/01/20 End: 02/28/26 Due: 02/28/27

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT06033807 Org: User:
Start: 09/01/23 End: 12/31/25 Due: 12/31/26

TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts

Phase: N/A Priority: Normal
NCT ID: NCT06022146 Org: User:
Start: 09/01/23 End: 09/01/26 Due: 09/01/27